OMNI BIO PHARMACEUTICAL, INC. Contracts & Agreements

ASSIGNMENT AGREEMENT AND COVENANT NOT TO SUE (Filed With SEC on June 25, 2015)

ASSIGNMENT, BILL OF SALE AND CONVEYANCE (Filed With SEC on June 25, 2015)

PATENT ASSIGNMENT (Filed With SEC on June 25, 2015)

Omni Bio Pharmaceutical, Inc. SECOND AMENDED SECURED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on March 13, 2015)

SECOND MODIFICATION AND EXCHANGE AGREEMENT (Filed With SEC on March 13, 2015)

CONSULTING AGREEMENT (Filed With SEC on February 14, 2013)

WARRANT TO PURCHASE SHARES OF COMMON STOCK OF OMNI BIO PHARMACEUTICAL, INC. Warrant to Purchase 500,000 Shares of Common Stock (subject to adjustment as set forth herein) Exercise... (Filed With SEC on February 14, 2013)

WARRANT TO PURCHASE SHARES OF COMMON STOCK OF OMNI BIO PHARMACEUTICAL, INC. Warrant to Purchase 843,000 Shares of Common Stock (subject to adjustment as set forth herein) Exercise... (Filed With SEC on February 14, 2013)

$600,000.00October 31, 2012Denver, Colorado SENIOR SECURED 10% CONVERTIBLE PROMISSORY NOTE DUE OCTOBER 31, 2015 (Filed With SEC on February 14, 2013)

WARRANT TO PURCHASE SHARES OF COMMON STOCK OF OMNI BIO PHARMACEUTICAL, INC. Warrant to Purchase 600,000 Shares of Common Stock (subject to adjustment as set forth herein) Exercise... (Filed With SEC on February 14, 2013)

EMPLOYMENT AGREEMENT (Filed With SEC on December 20, 2012)

Exhibit 10.1EXCLUSIVE LICENSE AGREEMENT TABLE OF CONTENTS Section 1 Definitions Section 2 Grant and Reservation of Rights Section 3 Economic Consideration Section 4 Sublicensing... (Filed With SEC on October 2, 2012)

IMPORTANT:PLEASE READ CAREFULLY BEFORE SIGNING. SIGNIFICANT REPRESENTATIONS ARE CALLED FOR HEREIN. SUBSCRIPTION AGREEMENT and LETTER OF INVESTMENT INTENT (Filed With SEC on August 14, 2012)

No. [2012-__] Principal Amount $________Issue Date:_______, 2012 SERIES A SENIOR SECURED 10% CONVERTIBLE PROMISSORY NOTE DUE____, 2015 [36 months from the Issue Date] (Filed With SEC on August 14, 2012)

PLEDGE AND SECURITY AGREEMENT (Filed With SEC on August 14, 2012)

WARRANT TO PURCHASE SHARES OF COMMON STOCK OF OMNI BIO PHARMACEUTICAL, INC. Warrant to PurchaseShares of Common Stock (subject to adjustment as set forth herein) Exercise Price... (Filed With SEC on August 14, 2012)

AMENDMENT ONE TO SPONSORED RESEARCH AGREEMENT (Filed With SEC on August 14, 2012)

SPONSORED RESEARCH AGREEMENT (NON-CLINICAL) (Filed With SEC on July 12, 2012)

Financial Statements (Filed With SEC on August 15, 2011)

STOCKHOLDERS AGREEMENT (Filed With SEC on July 21, 2011)

Stock Purchase Agreement (Filed With SEC on July 21, 2011)

Date of Issuance Void afterJuly 15, 2011 July 15, 2012 BIOMIMETIX PHARMACEUTICAL, INC. WARRANT TO PURCHASE SHARES OF COMMON STOCK (Filed With SEC on July 21, 2011)

SPONSORED RESEARCH AGREEMENT (Filed With SEC on September 9, 2010)

SPONSORED RESEARCH AGREEMENT (Filed With SEC on August 24, 2010)

INVESTIGATIONAL SITE AGREEMENT (Filed With SEC on July 30, 2010)

MATERIAL TRANSFER AGREEMENT (Filed With SEC on July 30, 2010)

IMPORTANT:PLEASEREAD CAREFULLY BEFORE SIGNING. SIGNIFICANTREPRESENTATIONS ARE CALLED FOR HEREIN. SUBSCRIPTIONAGREEMENT and LETTER OFINVESTMENT INTENT (Filed With SEC on February 4, 2010)

WARRANTTO PURCHASE SHARES OFCOMMON STOCK OFOMNI BIO PHARMACEUTICAL, INC. Warrantto Purchase _____ Shares of Common Stock (subjectto adjustment as set forth herein) ExercisePrice... (Filed With SEC on February 4, 2010)

WARRANTTO PURCHASE SHARES OFCOMMON STOCK OFOMNI BIO PHARMACEUTICAL, INC. Warrantto Purchase 600,000 Shares of Common Stock (subjectto adjustment as set forth herein) ExercisePrice... (Filed With SEC on December 22, 2009)

WARRANTTO PURCHASE SHARES OFCOMMON STOCK OFOMNI BIO PHARMACEUTICAL, INC. Warrantto Purchase 300,000 Shares of Common Stock (subjectto adjustment as set forth herein) ExercisePrice... (Filed With SEC on December 22, 2009)

LICENSE AGREEMENT (Filed With SEC on October 2, 2009)

AGREEMENTAND PLAN OF MERGER Between MAXCUREPHARMACEUTICAL, INC., and APROBIO PHARMACEUTICAL CORPORATION Datedas of March 18, 2008 TABLEOF CONTENTS (Filed With SEC on June 29, 2009)

Exhibit 10.11 FORMOF ADVISOR WARRANT (Filed With SEC on June 29, 2009)

IMPORTANT:PLEASEREAD CAREFULLY BEFORE SIGNING. SIGNIFICANTREPRESENTATIONS ARE CALLED FOR HEREIN. SUBSCRIPTIONAGREEMENT and LETTER OFINVESTMENT INTENT (Filed With SEC on June 29, 2009)

FORMOF INVESTOR WARRANT (Filed With SEC on June 29, 2009)

FORMOF TWO-YEAR SUBSCRIPTION AND LOCK-UP AGREEMENT (Filed With SEC on June 29, 2009)

FORMOF THREE-YEAR SUBSCRIPTION AND LOCK-UP AGREEMENT (Filed With SEC on June 29, 2009)

THIRDAGREEMENT TO AMEND AND EXTEND AGREEMENT OF MERGER AND PLAN OFREORGANIZATION (Filed With SEC on April 6, 2009)

EXCLUSIVELICENSE AGREEMENT (Filed With SEC on April 6, 2009)

APROBIO PHARMACEUTICAL CORPORATION SUBSCRIPTIONAGREEMENT (Filed With SEC on April 6, 2009)

SPONSOREDRESEARCH AGREEMENT (Filed With SEC on April 6, 2009)

SERVICESAGREEMENT (Filed With SEC on April 6, 2009)

Page 1 of26 (Filed With SEC on April 6, 2009)

EXCLUSIVE LICENSEAGREEMENT (Filed With SEC on April 6, 2009)

Agreement (Filed With SEC on April 6, 2009)

SECOND AGREEMENT TO AMENDAND EXTEND AGREEMENT OF MERGER AND PLAN OF REORGANIZATION (Filed With SEC on March 13, 2009)

AGREEMENTTO AMEND AND EXTEND AGREEMENT OF MERGERAND PLAN OF REORGANIZATION (Filed With SEC on February 18, 2009)

AGREEMENTOF MERGER AND PLAN OFREORGANIZATION among ACROSSAMERICA FINANCIAL SERVICES, INC. ACROSSAMERICA ACQUISITION CORP. and APRO BIOPHARMACEUTICAL CORPORATION NOVEMBER17, 2008 (Filed With SEC on November 21, 2008)

SENIORSECURED CONVERTIBLE PROMISSORY NOTE $132,000 October 16, 2008 (Filed With SEC on November 7, 2008)

Category

Industry

Companies

Contracts

OMNI BIO PHARMACEUTICAL, INC. Contracts & Agreements